Intensity Therapeutics
INTS
21 hedge funds and large institutions have $5.1M invested in Intensity Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
6% more capital invested
Capital invested by funds: $4.79M → $5.1M (+$309K)
5% more funds holding
Funds holding: 20 → 21 (+1)
0.95% less ownership
Funds ownership: 18% → 17.05% (-0.95%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sapient Capital
Indianapolis,
Indiana
|
+$75.5K |
| 2 |
SL
Sentinus LLC
Oak Brook,
Illinois
|
+$60.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.4K |
| 4 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$44.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$31.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$566K |
| 2 |
GS
GTS Securities
Miami,
Florida
|
-$33.7K |
| 3 |
BlackRock
New York
|
-$945 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$612 |
INTS Hedge Fund Activity: Q1 2025 in Review
21 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Intensity Therapeutics (INTS) for Q1 2025, worth a combined $5.1M — up 6.4% from $4.79M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new INTS positions and 1 closed out — a net gain of 2 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Sapient Capital, adding an estimated $75.5K. The largest seller was Armistice Capital, cutting an estimated $566K.
- 21 institutional investors held Intensity Therapeutics (INTS) as of Q1 2025, up from 20 in Q4 2024.
- Funds reported $5.1M of Intensity Therapeutics stock for Q1 2025, up 6.4% quarter-over-quarter.
- 3 funds opened new Intensity Therapeutics positions in Q1 2025 and 1 closed out, a net change of +2 holders.
- The largest Intensity Therapeutics buyer in Q1 2025 was Sapient Capital, an estimated $75.5K added.
- The largest Intensity Therapeutics seller in Q1 2025 was Armistice Capital, an estimated $566K sold.
Based on aggregated 13F filings for Q1 2025.